These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8555600)

  • 1. Dialysis fluid temperature and vasoactive substances during routine hemodialysis.
    Hegbrant J; Mãrtensson L; Ekman R; Nielsen AL; Thysell H
    ASAIO J; 1994; 40(3):M678-82. PubMed ID: 8555600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Ekman R; Boberg U
    Nephron; 1993; 63(3):303-8. PubMed ID: 8446268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma levels of vasoactive peptides during sequential bicarbonate hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Ekman R; Boberg U
    Nephron; 1993; 63(3):309-13. PubMed ID: 8446269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia.
    Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
    ASAIO J; 1992; 38(3):M197-200. PubMed ID: 1281014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of cold dialysate for the prevention of hemodialysis-induced hypoxia.
    Hegbrant J; Sternby J; Larsson A; Mårtensson L; Lassen Nielsen A; Thysell H
    Blood Purif; 1997; 15(1):15-24. PubMed ID: 9096903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and vasoactive peptides in hemodialysis patients.
    Hegbrant J; Ekman R; Thysell H
    Blood Purif; 1998; 16(3):135-9. PubMed ID: 9681155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma levels of vasoactive substances during routine acetate and bicarbonate hemodialysis.
    Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
    Clin Nephrol; 1994 Feb; 41(2):106-12. PubMed ID: 8004826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment.
    Hegbrant J; Thysell H; Ekman R
    Scand J Urol Nephrol; 1992; 26(2):169-76. PubMed ID: 1378231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed decrease in plasma levels of atrial natriuretic peptide during cold hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Nielsen AL; Lindberg BF
    Nephron; 1994; 68(4):427-32. PubMed ID: 7870226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive agents and blood pressure regulation in sequential ultrafiltration and hemodialysis.
    Odar-Cederlöf I; Theodorsson E; Eriksson CG; Hamberger B; Tidgren B; Kjellstrand CM
    Int J Artif Organs; 1993 Sep; 16(9):662-9. PubMed ID: 8294159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
    Heintz B; Königs F; Dakshinamurty KV; Kierdorf H; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H
    Nephron; 1993; 65(2):266-72. PubMed ID: 8247191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is neuropeptide Y a contributor to volume-induced hypertension?
    Odar-Cederlöf I; Ericsson F; Theodorsson E; Kjellstrand CM
    Am J Kidney Dis; 1998 May; 31(5):803-8. PubMed ID: 9590190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients.
    Heintz B; Reiners K; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H; Sieberth HG
    Clin Nephrol; 1993 Apr; 39(4):198-204. PubMed ID: 8491049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive hormones in children with chronic renal failure.
    Rauh W; Hund E; Sohl G; Rascher W; Mehls O; Schärer K
    Kidney Int Suppl; 1983 Nov; 15():S27-33. PubMed ID: 6368949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concentration of neuropeptide Y in serum of patients with primary hypertension].
    Halawa B; Salomon P
    Pol Arch Med Wewn; 1996 May; 95(5):420-6. PubMed ID: 8848409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced skin reactivity to vasoconstrictor and vasodilator substances in atopic eczema.
    Zirbs M; Reindel U; Hermann K; Church MK; Behrendt H; Ring J; Brockow K
    Eur J Dermatol; 2013; 23(6):812-9. PubMed ID: 24201043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium.
    Pernow J
    Br J Pharmacol; 1989 Jul; 97(3):983-9. PubMed ID: 2474355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neuropeptide Y concentrations in patients on hemodialysis.
    Akagi S; Nagake Y; Sugimoto T; Nakao K; Yamasaki H; Ichikawa H; Makino H
    Nephron; 2002 Oct; 92(2):333-8. PubMed ID: 12218311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic and sensory nerve activation during negative pressure therapy of sternotomy wounds.
    Torbrand C; Wackenfors A; Lindstedt S; Ekman R; Ingemansson R; Malmsjö M
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1067-70. PubMed ID: 18784122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.